4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-21-014543
Chief Commercial Officer sold 8,554 shares at $2.09 ($17,861)
From the SEC's structured data for this filing
Trades in this filing
Evanson Jeff · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-23 | Sale : show line 1 in the form | −8,554 | $2.09 | $17,861 | 1,141,930 | D |
| Open-market sales · 8,554 sh · avg $2.09 · $17,861 | ||||||
Loading xslF345X03/doc4.xml…